Idorsia Secures CHF 250 Million Financing Facility to Strengthen Balance Sheet and Extend Cash Runway

Senior secured term loan of up to CHF 250 million with a 5‑year maturity at a fixed 7% interest rate First tranche will fully refinance the existing...

June 10, 2026 | Wednesday | News
Advanced NanoTherapies Secures $31 Million Series B to Advance Dual-Drug Balloon Platform for Vascular Disease

Advanced NanoTherapies, Inc. (ANT), a clinical-stage medtech company dedicated to improving outcomes for patients with coronary and peripheral artery dis...

June 04, 2026 | Thursday | News
NunaBio Secures £6.5 Million to Scale Next-Generation DNA Manufacturing Platform

NunaBio, a next-generation DNA manufacturing company, has secured £6.5 million in funding to scale-up its proprietary DNA platform and accelerate i...

May 18, 2026 | Monday | News
Nxera Launches New GPCR-Focused Spinout to Advance NxWave™ Program Through Global Clinical Development

New company (“NewCo”) co-founded by Nxera with a syndicate of leading healthcare and life sciences-focused investment firms. In return for...

May 12, 2026 | Tuesday | News
Solid Biosciences Doses First Patient in Phase 3 IMPACT DUCHENNE Trial Advancing SGT-003 for Duchenne Muscular Dystrophy

- Initiation of Phase 3 IMPACT DUCHENNE placebo-controlled, randomized, double-blind trial as part of Solid’s integrated, multi-trial development p...

May 08, 2026 | Friday | News
Eli Lilly and Company Bets US$4.5 Billion on Indiana to Build the Future of Pharmaceutical Manufacturing

Eli Lilly and Company has announced an additional US$4.5 billion investment into its Indiana manufacturing network, deepening one of the mo...

May 07, 2026 | Thursday | Analysis
Amgen Invests Additional $300 Million to Expand U.S. Biomanufacturing Capacity in Puerto Rico

Investment Strengthens American Manufacturing, Supply Chain Resilience and Next-Generation Technology Amgen announced plans to invest an additional $300...

May 06, 2026 | Wednesday | News
Lunai Bioworks Expands CNS Platform with $20 Million IP Acquisition to Advance Alzheimer’s and Neurotherapeutic Programs

Transaction Adds Dual BBB Delivery Strategies, Supports Alzheimer's Programs, Combination Therapies, 505(b)(2) Pathways, and CNS Countermeasure Applicati...

May 06, 2026 | Wednesday | News
FreeMind Investments and Daewoong Pharmaceutical Invest in General Proximity to Advance Induced Proximity Therapeutics

FreeMind Investments (FMI), a venture capital fund launched in partnership between FreeMind Group and Daewoong Pharmaceutical Co., Ltd., announced its in...

May 06, 2026 | Wednesday | News
UCB to Acquire Candid Therapeutics in Up to $2.2 Billion Deal to Expand Next-Generation Immunology Portfolio

Deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next-generation biologics with potential for i...

May 05, 2026 | Tuesday | News
TrialClinIQ Secures Pre-Seed Funding and Accelerator Backing to Advance Equitable Clinical Trial Access

TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, announced a $150K pre-seed investment fro...

April 30, 2026 | Thursday | News
PCI Pharma Services Commits Over $1 Billion to Expand Sterile Fill-Finish and Drug-Device Capabilities Across US and Europe

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on i...

April 29, 2026 | Wednesday | News
AbbVie Commits $1.4B to Build North Carolina Manufacturing Campus in Largest-Ever Site Investment

Marks AbbVie's largest-ever capital investment in a single campus since its inception Investment demonstrates continued progress a...

April 24, 2026 | Friday | News
10x Science Raises $4.8M Seed to Transform Molecular Protein Characterization with Explainable AI

10x Science, which builds frontier AI for molecular-level protein characterization across the life sciences, today announced the closing of its $4.8M seed ...

April 24, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close